What is the recommended dosing regimen for a hydrocortisone intravenous continuous infusion (drip) in an adult patient?

Hydrocortisone Continuous Intravenous Infusion Dosing

For adult patients requiring hydrocortisone continuous IV infusion, administer 200 mg over 24 hours, optionally preceded by a 50–100 mg IV bolus, for conditions including adrenal crisis, septic shock, and major surgical stress. 1

Primary Indications & Dosing

Acute Adrenal Crisis

• Initial bolus: Give 100 mg hydrocortisone IV immediately, followed by 200 mg/24 h continuous infusion (or 50 mg IV every 6 hours as an acceptable alternative). 1
• Concurrent fluid resuscitation: Infuse 1 L isotonic saline during the first hour; adjust rate and volume based on hemodynamic monitoring. 1
• Duration: Continue IV therapy for 24–48 hours until hemodynamically stable and oral intake is possible. 1
• Transition: Switch to oral hydrocortisone at three times the usual maintenance dose (minimum 60 mg/day) divided TID; maintain for 48 hours in uncomplicated cases or up to 1 week if recovery is delayed. 1

Septic Shock (Refractory to Fluids & Vasopressors)

• Indication threshold: Initiate when shock persists despite adequate fluid resuscitation and vasopressor therapy >0.1 µg/kg/min norepinephrine. 1, 2
• Regimen: 200 mg/24 h continuous IV infusion (preferred) or 50 mg IV every 6 hours (equally effective alternative). 1, 2
• Duration: Administer for ≥3 days at full dose, typically 7–14 days total before tapering. 1, 2
• Evidence: Low-dose, prolonged regimen reduces 28-day mortality and accelerates shock reversal compared to high-dose, short-course therapy. 1

Major Surgery & Peri-operative Stress

• Regimen: 100 mg IV at induction, then 200 mg/24 h continuous infusion (or 50 mg IV every 6 hours) until oral intake resumes. 1, 2
• Post-operative transition: Double the oral dose for 48 hours (or up to 1 week if recovery is complicated), then taper to maintenance. 1

Continuous Infusion vs. Intermittent Bolus

Continuous IV infusion of 200 mg/24 h is superior for maintaining physiological stress cortisol levels during major stress. 1, 3

• Pharmacokinetic evidence: Continuous infusion is the only administration mode that persistently achieves median cortisol concentrations in the range observed during major stress (surgery, sepsis, trauma). 3
• Linear modeling: Continuous infusion of 200 mg/24 h, preceded by an initial 50–100 mg bolus, best maintains cortisol in the required therapeutic range. 3
• Acceptable alternative: If continuous infusion is unavailable, 50 mg IV every 6 hours (total 200 mg/day) provides equivalent total daily exposure and is guideline-supported. 1, 2
• Shock reversal data: One RCT showed intermittent bolus (50 mg q6h) achieved higher shock reversal at day 7 compared to continuous infusion (66% vs. 35%, P=0.008), though this finding requires validation. 4

Preparation & Administration (FDA Label)

• Reconstitution: Add ≤2 mL Bacteriostatic Water for Injection to the vial. 5
• Dilution for infusion: Add reconstituted solution to 100–1000 mL of 5% dextrose in water, isotonic saline, or 5% dextrose in isotonic saline (if patient is not sodium-restricted). 5
• Infusion rate for bolus: Administer IV bolus over 30 seconds (100 mg) to 10 minutes (500 mg or more). 5
• Stability: Reconstituted solutions are stable for at least 4 hours. 5
• Incompatibility: Do not dilute or mix with other solutions due to possible physical incompatibilities. 5

Monitoring & Safety

• Electrolytes: Monitor sodium and potassium regularly; hypernatremia may occur with high-dose therapy beyond 48–72 hours. 1, 2, 5
• Glucose: Watch for hyperglycemia, the most common adverse effect; adjust insulin as needed. 1, 2
• Blood pressure: Monitor closely, especially in patients with primary adrenal insufficiency receiving mineralocorticoid replacement. 1
• No increased infection risk: At doses <400 mg/day, no increased risk of super-infection or gastrointestinal bleeding has been demonstrated. 1

Tapering & Discontinuation

• Gradual taper required: After >48–72 hours of high-dose hydrocortisone or >14 days of any glucocorticoid, taper gradually to avoid precipitating adrenal crisis. 1, 2
• Fludrocortisone timing: Do not restart fludrocortisone until hydrocortisone dose has been reduced to <50 mg/day in primary adrenal insufficiency. 1
• Abrupt cessation contraindicated: FDA labeling explicitly states that after long-term therapy, withdraw gradually rather than abruptly. 5

Common Pitfalls

• Do not delay treatment: Administer hydrocortisone immediately in suspected adrenal crisis without waiting for laboratory confirmation; rapid clinical improvement is the best diagnostic indicator. 1
• Avoid etomidate: In patients with known or suspected adrenal insufficiency, avoid etomidate; if unavoidable, give 100 mg hydrocortisone IV immediately before or after induction. 1
• Do not use in sepsis without shock: Corticosteroids provide no mortality benefit in sepsis without shock and are not recommended. 2
• Avoid in influenza: Observational data suggest increased mortality (OR ≈3.1) and higher risk of super-infection; steroids should be avoided. 2
• High-dose duration limit: High-dose corticosteroid therapy should be continued only until the patient's condition has stabilized, usually not beyond 48–72 hours. 5